Ironwood Pharmaceuticals | IRWD - 営業利益





営業利益 変化する 日付
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Almirall EUR 71.55M 41.32M 2026-06
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amarin USD -2.26M 564K 2025-12
Ardelyx USD -32.79M 37.89M 2026-03
Astellas Pharma JPY 48.57B 85.97B 2026-03
AstraZeneca USD 3.16B 3.95B 2026-06
Charles River Laboratories USD 119.9M 44.08M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Emergent BioSolutions USD -218M 69.9M 2023-06
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Incyte USD 700.4M 376.22M 2026-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
MacroGenics USD -33.44M 21.34M 2026-03
Moderna USD -815M 573M 2026-06
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 4.62M 1.43M 2026-03
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD 22.08M 24.26M 2024-09
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Takeda JPY 201.42B 215.04B 2026-06
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12